Dwindling indications for sural nerve biopsy

Archives of Neurology

Volumn 64, Issue 7, 2007, Pages 935-936

  Pleasure, David E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; NEUROFILAMENT LIGHT CHAIN PROTEIN; UNCLASSIFIED DRUG;

BRAIN TUMOR; EDITORIAL; FAMILY HISTORY; GENE DELETION; GENE MUTATION; GENETIC PREDISPOSITION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; NERVE BIOPSY; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; SURAL NERVE;

BIOPSY; DNA MUTATIONAL ANALYSIS; HUMANS; MUTATION; MYELIN PROTEINS; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYRADICULONEUROPATHY; SKIN; SURAL NERVE;

EID: 34447252357     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.7.935     Document Type: Editorial

References (15)

1. Chao C-C, Hsieh S-T, Shun C-T, Hsieh S-C. Skin denervation and cutaneous vasculitis in eosinophilia-associated neuropathy. Arch Neurol. 2007;64(7):959-965.
2. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094-1100.
3. Miltenberger-Miltenyi G, Janecke AR, Wanschitz JV, et al. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene. Arch Neurol. 2007;64(7):966-970.
4. Jordanova A, De Jonghe P, Boerkoel CF, et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain. 2003;126(Pt 3):590-597.
5. Li J, Ghandour K, Radovanovic D, et al. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies. Arch Neurol. 2007;64(7):974-978.
6. Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993;72(1):143-151.
7. Inoue K, Dewar K, Katsanis N, et al. The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes. Genome Res. 2001;11(6):1018-1033.
8. Li J, Bai Y, Ghandour K, et al. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain. 2005;128(pt 5):1168-1177.
9. Lee J-E, Shun C-T, Hsieh S-C, Hsieh S-T. Skin denervation in vasculitic neuropathy. Arch Neurol. 2005;62(10):1570-1573.
10. McArthur JC, Stocks A, Hauer P, et al. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol. 1998;55(12):1513-1520.
11. Li J, Bai Y, Ianakova E, et al. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration. J Comp Neurol. 2006;498(2):252-265.
12. Theriault M, Dort J, Surtherland G, Zochodne DW. A prospective quantitative study of sensory deficits after whole sural nerve biopsies in diabetic and nondiabetic patients: surgical approach and the role of collateral sprouting. Neurology. 1998;50(2):480-484.
13. Flachenecker P, Janka M, Goldbrunner R, Toyka KV. Clinical outcome of sural nerve biopsy: a retrospective study. J Neurol. 1999;246(2):93-96.
14. Neundorfer B, Grahmann F, Engelhardt A, Harte U. Postoperative effects and value of sural nerve biopsies: a retrospective study. Eur Neurol. 1990;30(6):350-352.
15. Solders G. Discomfort after fascicular sural nerve biopsy. Acta Neurol Scand. 1988;77(6):503-504.